Chung CH, Li J, Steuer CE, Bhateja P, et al. Phase II multi-institutional clinical trial result of concurrent cetuximab and nivolumab in recurrent and/or metastatic head and neck squamous cell carcinoma. Clin Cancer Res 2022 Mar 28. pii: 694028. doi: 10.1158/1078-0432.CCR-21-3849.
PMID: 35344035